RECARBRIO 500 mg/500 mg/250 mg, powder for solution for infusion 25 bottles of 20 ml
Active ingredients: Cilastatin, Cilastatin sodium, IMIPÉNEM ANHYDRE, Imipenem hydrate, Relebactam, Relebactam monohydrate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for solution for infusion25 bottles of 20 mlintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- RECARBRIO 500 mg/500 mg/250 mg, poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 25 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Dec 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65172663CIP73020126CIP133400930201268Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IMIPÉNEM MONOHYDRATÉpoudre | — | SA |
| CILASTATINE SODIQUEpoudre | — | SA |
| IMIPÉNEM ANHYDREpoudre | 500 mg · un flacon | FT |
| RÉLÉBACTAMpoudre | 250 mg · un flacon | FT |
| CILASTATINEpoudre | 500 mg · un flacon | FT |
| RÉLÉBACTAM MONOHYDRATÉpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.